Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Example Input: Trump even suggested Thursday that the release could have been intentional. The Office of the Director of National Intelligence, the clearinghouse for the web of U.S. spy agencies, said it had ruled out the virus being man-made but was still investigating the precise source of the global pandemic, which has killed more than 220,000 people worldwide. Though scientists suggest the likeliest origin of the pandemic remains natural, that it spread from an infected animal to a human, Trump claimed to have seen evidence to support the theory that the origin was an infectious disease lab in Wuhan, the epicenter of the Chinese outbreak. He said the U.S. now “is finding how it came out.” “It’s a terrible thing that happened,” the president said. “Whether they made a mistake or whether it started off as a mistake and then they made another one, or did somebody do something on purpose.” The intel statement said the federal agencies concur “with the wide scientific consensus that the COVID-19 virus was not manmade or genetically modified.” “The IC will continue to rigorously examine emerging information and intelligence to determine whether the outbreak began through contact with infected animals or if it was the result of an accident at a laboratory in Wuhan.” In recent days the Trump administration has sharpened its rhetoric on China, accusing the geopolitical foe and vital trading partner of failing to act swiftly enough to sound the alarm about the outbreak or to stop the spread of the virus that causes COVID-19. U.S. officials have said the Chinese government should “pay a price” for its handling of the pandemic. This all comes as the pace of Trump’s own original response continues to come under scrutiny, questioned as too meager and too slow. Earlier Thursday, before Trump’s comments, the Chinese government said that any claims that the coronavirus was released from a laboratory are “unfounded and purely fabricated out of nothing.” Foreign Ministry spokesman Geng Shuang cited the institute’s director, Yuan Zhiming, as saying the lab strictly implements bio-security procedures that would prevent the release of any pathogen. “I would like to point out again that the origin of the virus is a complex scientific issue, and it should be studied by scientists and professionals,” Geng said. He also criticized those in the U.S. who say China should be held accountable for the global pandemic, saying they should spend their time on “better controlling the epidemic situation at home.” At the White House, Trump repeatedly blamed China for its handling of the outbreak, criticizing the country for restricting domestic travel to slow the virus but not international travel to keep it from spreading abroad. “Certainly it could have been stopped,” Trump said during an event in the East Room on his administration’s efforts to aid seniors during the outbreak. “They either couldn’t do it from a competence standpoint, or they let it spread.” “It got loose, let’s say, and they could have capped it.” Earlier this month, Trump addressed the lab theory saying, “More and more, we’re hearing the story.” Secretary of State Mike Pompeo added at the time, “The mere fact that we don’t know the answers — that China hasn’t shared the answers — I think is very, very telling.” Pompeo also pressed China to let outside experts into the lab “so that we can determine precisely where this virus began.” While Trump and Pompeo have made their feelings clear, a U.S. intelligence official disputed the notion that there was pressure on agencies to bolster a particular theory. The intelligence official was not authorized to publicly discuss the issue and spoke only on condition of anonymity. Scientists say the virus arose naturally in bats. Even so, Pompeo and others have pointed fingers at an institute that is run by the Chinese Academy of Sciences. It has done groundbreaking research tracing the likely origins of the SARS virus, finding new bat viruses and discovering how they could jump to people. “We know that there is the Wuhan Institute of Virology just a handful of miles away from where the wet market was,” Pompeo said two weeks ago. The institute has an address 8 miles, or 13 kilometers, from the market that is considered a possible source. U.S. officials say the American Embassy in Beijing flagged concerns about potential safety issues at the lab in Wuhan in 2018, but they have yet to find any evidence the virus originated there nearly two years later. Scientists studying the virus for months have made clear they believe it wasn’t man-made but are still working to determine a point at which it may have jumped from animals to humans. Early attention focused on the live-animal market in Wuhan where the first cases were reported in December. But the first person identified with the disease had no known connection to that market. Kristian Andersen, who studies the virus at Scripps Research in La Jolla, California, puts the odds of it being accidentally released by the Wuhan lab at “a million to one,” far less likely than an infection in nature. But virus expert David O’Connor of the University of Wisconsin-Madison said he thinks too little is known to rule out any source, except the idea the virus was man-made. Finding the source is important, he said, because it may harbor the next pandemic virus. The U.S. was providing funding to the Wuhan lab for its research on coronaviruses, Michael Morell, former acting director and deputy director of the CIA, said Thursday. He said State Department cables indicate that there have been concerns in past years among U.S. officials about the safety protocols at that lab. If the virus did escape from a Chinese lab, it not only reflects negatively on China but also on the United States for providing research funding to a lab that has safety concerns, Morell said during an online forum hosted by the Michael V. Hayden Center for Intelligence, Policy and International Security at George Mason University. “So if it did escape, we’re all in this together,” Morell said. “This is not a gotcha for China. This is a gotcha for both of us.” ___ Associated Press writers Deb Riechmann in Washington and Malcolm Ritter in New York contributed to this report.
Example Output: Trump speculates that China released virus in lab ‘mistake’.

Example Input: On 10 May 1991, a 14-year-old Boy Scout named David Hahn earned an Atomic Energy merit badge, the first (and likely only) person in the history of Troop 371 in Clinton Township, Michigan, to receive a badge in that discipline: David was awarded his Atomic Energy merit badge on May 10, 1991, five months shy of his fifteenth birthday. To earn it he made a drawing showing how nuclear fission occurs, visited a hospital radiology unit to learn about the medical uses of radioisotopes and built a model reactor using a juice can, coat hangers, soda straws, kitchen matches, and rubber bands. By now, though, David had far grander ambitions. Throughout his childhood, Hahn had been obsessed with chemistry, teaching himself everything he knew from encyclopedias, textbooks, and chemistry sets, while personal safety did not seem to be a concern of his. According to a 1998 Harper’s profile of Hahn written by Ken Silverstein, “He once appeared at a scout meeting with a bright orange face caused by an overdose of canthaxanthin, which he was taking to test methods of artificial tanning.” In another instance, he was held responsible for a blowing a large hole in the wall of a Boy Scout tent after accidentally igniting a stockpile of powdered magnesium he had brought along. His “laboratory” was eventually moved to the potting shed behind his mother’s house, after an incident in his father’s basement that did not go as planned: One night as [Hahn’s father and stepmother] were sitting in the living room watching TV, the house was rocked by an explosion in the basement. There they found David lying semiconscious on the floor, his eyebrows smoking. Unaware that red phosphorus is pyrophoric, David had been pounding it with a screwdriver and ignited it. After achieving the rank of Eagle Scout, Hahn decided he wanted to experiment with real radioactivity, not merely the models he had used to earn his badge. He created various radioactive devices, including two different “neutron guns” that emitted radioactive particles, and eventually decided he wanted to create a “breeder reactor” — an energy generating nuclear reactor that actually produces more fissile material than it consumes (by essentially turning material around it radioactive). The concept was popular in the 1970s but for the most part has been abandoned thanks to modern technology and geologic finds that make mining uranium more cost-efficient. The breeder reactor concept was described by the Department of Energy in 1971 as follows: A breeder is a reactor that produces more fuel than it consumes … If the breeder can be used in a nuclear power plant, it can provide the heat needed for the generation of electricity and simultaneously produce an excess of fissionable material that can be used to fuel other plants. The answer to this apparent contradiction is that breeder reactors do not give “something for nothing”, but produce usable fissionable material from comparatively useless fertile material at a greater rate than the original fuel in the reactor is consumed in the fissioning process. The obvious question is how would an adolescent working out of his mother’s potting shed acquire fissile material to play around with? This is where Hahn’s myopic focus and determination really shined: Many household products (and even more in the 1990s) contain radioactive material, but the problem is scale. Hahn exploited several commonly found products and used his knowledge of chemistry to extract and concentrate it to create radioactivity at levels “not found in nature.” Early on, one common source of Hahn’s radioactive material came from household smoke detectors, which contain extremely small amounts of the radioactive isotope americium-241 as part of the mechanism that detects smoke. He “contacted smoke-detector companies and claimed that he needed a large number of the devices for a school project.” To obtain the radioactive isotope thorium-232, Hahn recalled a fact he had learned as an Eagle Scout: that the mantle of gas lanterns contains traces of the radioactive material. So he purchased “thousands of lantern mantles from surplus stores and, using the blowtorch, reduced them into a pile of ash.” This method produced radiation levels “9,000 times the level found in nature and 170 times the level that requires [Nuclear Regulatory Commission] licensing.” Radium-226, he learned, was found in the paint of antique luminescent clocks. Hahn was able to find an antique can of the mildly radioactive paint in a clock at a nearby antique store, which he used to isolate the isotope for experiments. Tritium, he found, was used as a component of glow-in-the-dark gun and bow sights, which he repeatedly purchased and returned as part of a scheme to collect the material. Hahn “removed the tritium contained in a waxy substance inside the sights, and then, using a variety of pseudonyms, returned the sights to the store or manufacturer for repair—each time collecting another tiny quantity of tritium.” These purchases were not the only instances in which Hahn employed subterfuge to obtain radioactive material. Claiming to be a professor, he once wrote to a Czechoslovakian firm that sells uranium to commercial and university buyers, obtaining a few samples of material which contained uranium-235 and uranium-238. “Ignoring any thought of safety,” as Harper’s described it, he attempted to build a reactor using the radioactive material he had collected over the years, using a schematic in his father’s college chemistry textbook as his guide: [Hahn] took the highly radioactive radium and americium out of their respective lead casings and, after another round of filing and pulverizing, mixed those isotopes with beryllium and aluminum shavings, all of which he wrapped in aluminum foil. What were once the neutron sources for his guns became a makeshift “core” for his reactor. He surrounded this radioactive ball with a “blanket” composed of tiny foil-wrapped cubes of thorium ash and uranium powder, which were stacked in an alternating pattern with carbon cubes and tenuously held together with duct tape. While he never achieved the critical mass necessary for a self-sustaining reaction, Hahn certainly appeared to have accomplished the creation of some new fissile material: [Hahn] monitored his “breeder reactor” … with his Geiger counter. “It was radioactive as heck,” he says. “The level of radiation after a few weeks was far greater than it was at the time of assembly. I know I transformed some radioactive materials. Even though there was no critical pile, I know that some of the reactions that go on in a breeder reactor went on to a minute extent” … When his Geiger counter began picking up radiation five doors down from his mom’s house, David decided that he had “too much radioactive stuff in one place” and began to disassemble the reactor. He placed the thorium pellets in a shoebox that he hid in his mother’s house, left the radium and americium in the shed, and packed most of the rest of his equipment into the trunk of the Pontiac 6000. All of these events took place before the end of 1994, and perhaps they would have remained a secret to this day if Hahn had not stashed the remains of his nuclear reactor in that Pontiac. On 31 August 1994, police responded to complaints that Hahn was in a residential neighborhood “stealing tires from a car.” In their discussion with Hahn, the police ended up performing a search of the car and found: When they opened the trunk they discovered a toolbox shut with a padlock and sealed with duct tape for good measure. The trunk also contained over fifty foil-wrapped cubes of mysterious gray powder, small disks and cylindrical metal objects, lantern mantles, mercury switches, a clock face, ores, fireworks, vacuum tubes, and assorted chemicals and acids. The police were especially alarmed by the toolbox, which David warned them was radioactive and which they feared was an atomic bomb. The discovery of the radioactive contents of Hahn’s trunk “automatically triggered the Federal Radiological Emergency Response Plan, and state officials soon were embroiled in tense phone consultations with the DOE, EPA, FBI, and NRC.” After examining his mother’s property (which she had cleansed of the most radioactive material in advance of law enforcement searches of the property for fear she would lose her home), authorities decided that the site was to be an EPA clean-up operation: A Superfund cleanup took place between June 26 and 28 at a cost of about $60,000. After the moon-suited workers dismantled the potting shed with electric saws, they loaded the remains into thirty-nine sealed barrels placed aboard a semitrailer bound for Envirocare, a dump facility located in the middle of the Great Salt Lake Desert. There, the remains of [Hahn’s] experiments were entombed along with tons of low-level radioactive debris from the government’s atomic-bomb factories, plutonium-production facilities, and contaminated industrial sites. Hahn fell into a deep depression following this episode, according to Harper’s, which was likely exacerbated by his mother’s suicide in 1996. He enlisted in the armed forces and spent four years in the U.S. Navy followed by some time in the Marines Corps before returning to his home state of Michigan. In 2007 the FBI investigated claims that Hahn was storing radioactive material in his apartment. In an interview with the FBI, Hahn described his honorable discharge from the military and his struggles with paranoid schizophrenia in the years following his return home: Hahn advised that prior to joining the Navy in May, 1997, he got into trouble for stealing tires and rims from a vehicle. Hahn stated he was in the Navy for approximately five and a half years as a internal communication specialist as well as various other positions. Hahn said he then received his associates from Macomb Community College for Applied Science in Criminal Justice. Hahn advised that he then enlisted in the Marines in 2004. Hahn stated he was a truck driver for approximately a year and a half before he was honorably discharged. Hahn said after a few months living with his [REDACTED], Hahn moved to his current residence. Hahn advised that he does not currently have a job. Hahn stated he is on disability because he was diagnosed with paranoid schizophrenia. Hahn said he also has radiation poisoning from his prior contact with radioactive substances. Hahn advised that he is compliant with all his medications most of the time. Hahn stated he occasionally drinks while he is on his medications. Hahn ran into trouble with the law for stealing smoke detectors in 2007 as well, and he experienced repeated drug-related incidents in the years following. He died on 27 September 2016 at the age of 39, a death which was the result of alcohol poisoning, his father said: Citing a toxicology and autopsy report, Kenneth Hahn said his son was found with a dangerous level of blood alcohol content, 0.404, late in the evening on September 26, 2016 … Prior to his death, [Kenneth] Hahn accompanied his son to the Veterans Administration hospital for quarterly routine checkups. Medical staff there found no lingering ill effects from the earlier radiation exposure.
Example Output: In 1994, a 17-year-old Eagle Scout built a nuclear reactor in his mother’s backyard, an act that ultimately necessitated a Superfund cleanup.

Example Input: Abbott executives said the increase in manufacturing capacity will begin in the second half of this year and make room for the expected U.S. launch of the FreeStyle Libre 2. This next-generation device has been approved in Europe and is now under U.S. regulatory review. Abbott’s plans for Libre, its fastest-growing diabetes product, used by 1.5 million people worldwide, will be in focus when the company reports quarterly earnings on Wednesday. Jared Watkin, Abbott’s senior vice president for Diabetes Care, said in an interview that scale is a “huge part” of the company’s strategy for its glucose monitors. “When you’re making disposable diagnostic products, the more you can make, the lower the cost you can produce them at.”  While the Libre 2 has more features, including alarms for when blood sugar levels swing too low or high, Abbott plans to keep the U.S. price the same as its predecessor, Watkin said. Abbott started in diabetes care as a maker of inexpensive test strips and glucose meters. More recently, the company has sought to expand access to its so-called continuous glucose monitoring (CGM) devices - traditionally sold to type 1 diabetics in markets with generous insurance coverage. “It’s not good enough to bring this to a small, wealthy population. Diabetes is such a global epidemic that you need to bring products that can really make a dent in that,” Watkin said. Launched in Europe in 2014 and in the United States three years later, the FreeStyle Libre allows people with diabetes to track blood sugar levels without multiple daily finger sticks. A sensor attached to the back of the upper arm uses a thin filament under the skin to measure glucose every minute. Users check their blood sugar levels throughout the day by waving a reader, or smartphone, over the sensor. Major competitors Medtronic Plc (MDT.N) and Dexcom Inc (DXCM.O) critique the current Libre’s lack of automatic alerts that can help diabetics manage their disease. Yet they also are taking steps to introduce cheaper models themselves, executives told Reuters. Libre’s sales are expected to reach $1.5 billion this year, the company said. In April, Goldman Sachs estimated the global CGM market could reach $5 billion by 2021, up from $3.7 billion in 2019. Goldman projected Abbott’s 2021 sales at $2.7 billion compared to $1.7 billion for Dexcom and $894 million for Medtronic. In the past, CGMs were used almost exclusively by type 1 diabetics, whose bodies do not make insulin and who must inject themselves with the blood-sugar regulating hormone to survive. Increasingly, people with type 2 diabetes - the kind driven by obesity, lack of exercise and genetics - must also closely monitor their blood glucose and use insulin to manage their disease when it is not controlled by other medications and lifestyle changes. For now, Libre users include 1 million type 1 diabetic patients and half a million type 2. That’s a tiny sliver of the 425 million people with diabetes worldwide. Although not all diabetics need glucose monitors, “there is an element of scratching the surface at this point,” Watkin said. “The need to invest and bring up capacity is, we believe, going to be an ongoing activity for us.”   Two 14-day Libre sensors, a month’s supply, retail for $109. Abbott says most of its patients are commercially insured, and many pay as little as $10 out of pocket. In the United States, the company says, more than half of people in commercial health plans are covered, as well as any eligible diabetic person on Medicare, the federal program for the elderly and disabled. The device is also approved in 45 other countries, including Germany, Japan, Brazil, China and the United Arab Emirates. Medtronic told Reuters it offers a discounted price of $345 per month for uninsured patients. The company estimates that the typical insured patient pays $50 a month. Medicare does not cover the device. Dexcom’s G6 sensors retail online, with a discount, at around $350 for a month’s supply. Dexcom says 98 percent of all U.S. private insurers cover the device, and patients covered by commercial insurance pay an average of $50-$80 per month for sensors through pharmacies or durable medical equipment suppliers. It is covered by Medicare. Libre’s 14-day sensor is also longer-lasting. Dexcom’s sensors work for 10 days, and Medtronic’s for up to 7. Abbott was also the first company to introduce a product that can be used without routine finger stick tests to validate the sensor’s readings – a feature Dexcom later matched and Medtronic has not. Dr. Roy Beck, an endocrinologist at the Jaeb Center for Health Research in Tampa, Florida, said that Abbott’s FreeStyle Libre is “an excellent sensor” but not as accurate at detecting very low blood sugar as the devices from Dexcom, Medtronic or an implantable CGM made by Senseonics (SENS.A). That makes it less desirable for patients for whom this is a major issue, he said. Beck’s center has received research funding from Abbott and Dexcom. Medtronic and Dexcom executives say the current Libre does not compare with their devices when it comes to features such as alerting users to dangerous blood sugar changes and providing comprehensive trend data. “It’s the cheapest, but it’s not exactly in the same category,” said Mike Hill, vice president and general manager of Medtronic’s sensor business. Abbott countered that its sensor has best-in-class accuracy, and noted that the next-generation Libre 2 does have optional alarms. Still, Medtronic is considering making a cheaper sensor for patients who don’t need all the features of its current continuous monitor, Hill said. And next year, Dexcom plans to launch a cheaper, smaller, 14-day sensor developed in partnership with Verily, Alphabet Inc’s (GOOGL.O) life sciences division. Dexcom Chief Executive Kevin Sayer acknowledged that Abbott’s pricing strategy will affect the global market over time, and that Dexcom expects its own prices to come down. “We’ve planned for this,” he said.
Example Output:
You see a whole bunch of Korean cars here in the United States, and you don't see any American cars in Korea.